A multi-country trial can shorten enrolment and broaden the evidence base, but only when the operational plan accounts for how differently each country works. The earlier those differences are mapped, the fewer amendments and delays appear later.
Start with country selection, not site selection
Epidemiology, standard of care, regulatory timelines and import rules for investigational product should shape the country mix before any site is approached.
- Check whether the comparator reflects local standard of care
- Map ethics and regulatory approval timelines side by side
- Confirm depot and cold-chain options for each region
Harmonise documents early
Informed consent forms, translations and local amendments are a common source of drift. A single master document set with controlled local variations keeps sites aligned and inspection-ready.
